MedRhythms announced that it received a final pricing determination from CMS for its InTandem rehabilitation system.

Scientists are unraveling the mystery of what triggers Huntington’s disease, a devastating hereditary disorder that strikes ...

InTandem®, the company's flagship rehabilitation system for chronic stroke gait impairment, received a final pricing ...